Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 57% ± 18% | |
peripheral blood | 17 studies | 52% ± 17% | |
intestine | 15 studies | 57% ± 26% | |
brain | 9 studies | 22% ± 7% | |
kidney | 9 studies | 51% ± 23% | |
eye | 8 studies | 41% ± 20% | |
uterus | 6 studies | 65% ± 24% | |
lymph node | 6 studies | 67% ± 24% | |
pancreas | 5 studies | 45% ± 10% | |
liver | 5 studies | 43% ± 11% | |
placenta | 4 studies | 46% ± 18% | |
bone marrow | 4 studies | 30% ± 8% | |
adipose | 4 studies | 36% ± 14% | |
prostate | 4 studies | 43% ± 12% | |
skin | 4 studies | 54% ± 19% | |
breast | 4 studies | 76% ± 10% | |
ovary | 3 studies | 58% ± 19% | |
adrenal gland | 3 studies | 64% ± 13% | |
esophagus | 3 studies | 57% ± 25% | |
stomach | 3 studies | 45% ± 18% | |
thymus | 3 studies | 59% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 32264.92 | 180 / 180 | 98% | 245.86 | 420 / 430 |
stomach | 100% | 31529.22 | 358 / 359 | 97% | 232.49 | 277 / 286 |
uterus | 99% | 26863.57 | 169 / 170 | 97% | 296.60 | 445 / 459 |
lung | 99% | 34778.17 | 574 / 578 | 96% | 192.66 | 1111 / 1155 |
prostate | 96% | 16860.93 | 235 / 245 | 99% | 438.55 | 498 / 502 |
intestine | 97% | 21811.39 | 933 / 966 | 97% | 251.73 | 513 / 527 |
breast | 98% | 54457.89 | 448 / 459 | 95% | 217.18 | 1064 / 1118 |
pancreas | 96% | 16492.22 | 316 / 328 | 96% | 217.99 | 171 / 178 |
bladder | 100% | 26913.00 | 21 / 21 | 90% | 212.96 | 455 / 504 |
esophagus | 89% | 16581.11 | 1287 / 1445 | 99% | 219.74 | 181 / 183 |
thymus | 94% | 26399.32 | 611 / 653 | 94% | 377.74 | 569 / 605 |
kidney | 89% | 14275.20 | 79 / 89 | 95% | 270.53 | 852 / 901 |
skin | 96% | 30655.77 | 1737 / 1809 | 72% | 90.35 | 341 / 472 |
brain | 62% | 7191.62 | 1629 / 2642 | 97% | 237.35 | 684 / 705 |
adrenal gland | 60% | 8575.68 | 156 / 258 | 90% | 149.04 | 206 / 230 |
liver | 70% | 16240.54 | 158 / 226 | 80% | 110.72 | 325 / 406 |
ureter | 0% | 0 | 0 / 0 | 100% | 67.23 | 1 / 1 |
adipose | 99% | 52252.41 | 1195 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 249.38 | 44 / 45 |
blood vessel | 96% | 27139.64 | 1285 / 1335 | 0% | 0 | 0 / 0 |
muscle | 88% | 10596.80 | 704 / 803 | 0% | 0 | 0 / 0 |
heart | 85% | 14827.13 | 733 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 53% | 48.99 | 42 / 80 |
lymph node | 0% | 0 | 0 / 0 | 41% | 33.95 | 12 / 29 |
peripheral blood | 41% | 6726.15 | 377 / 929 | 0% | 0 | 0 / 0 |
spleen | 38% | 4690.86 | 92 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0034614 | Biological process | cellular response to reactive oxygen species |
GO_0034976 | Biological process | response to endoplasmic reticulum stress |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0043922 | Biological process | negative regulation by host of viral transcription |
GO_0071276 | Biological process | cellular response to cadmium ion |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0019046 | Biological process | release from viral latency |
GO_0060395 | Biological process | SMAD protein signal transduction |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0043923 | Biological process | positive regulation by host of viral transcription |
GO_2000144 | Biological process | positive regulation of DNA-templated transcription initiation |
GO_1902895 | Biological process | positive regulation of miRNA transcription |
GO_0043392 | Biological process | negative regulation of DNA binding |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_1904707 | Biological process | positive regulation of vascular associated smooth muscle cell proliferation |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0140467 | Biological process | integrated stress response signaling |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0000228 | Cellular component | nuclear chromosome |
GO_0035976 | Cellular component | transcription factor AP-1 complex |
GO_0000791 | Cellular component | euchromatin |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0008134 | Molecular function | transcription factor binding |
GO_0003677 | Molecular function | DNA binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0070412 | Molecular function | R-SMAD binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005096 | Molecular function | GTPase activator activity |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0140296 | Molecular function | general transcription initiation factor binding |
GO_0003723 | Molecular function | RNA binding |
GO_0044389 | Molecular function | ubiquitin-like protein ligase binding |
GO_0035497 | Molecular function | cAMP response element binding |
GO_0005515 | Molecular function | protein binding |
Gene name | JUN |
Protein name | Transcription factor Jun (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (Transcription factor AP-1 subunit Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39) Transcription factor Jun (Activator protein 1) (Proto-oncogene c-Jun) (Transcription factor AP-1 subunit Jun) (V-jun avian sarcoma virus 17 oncogene homolog) |
Synonyms | |
Description | FUNCTION: Transcription factor that recognizes and binds to the AP-1 consensus motif 5'-TGA[GC]TCA-3' . Heterodimerizes with proteins of the FOS family to form an AP-1 transcription complex, thereby enhancing its DNA binding activity to the AP-1 consensus sequence 5'-TGA[GC]TCA-3' and enhancing its transcriptional activity (By similarity). Together with FOSB, plays a role in activation-induced cell death of T cells by binding to the AP-1 promoter site of FASLG/CD95L, and inducing its transcription in response to activation of the TCR/CD3 signaling pathway . Promotes activity of NR5A1 when phosphorylated by HIPK3 leading to increased steroidogenic gene expression upon cAMP signaling pathway stimulation . Involved in activated KRAS-mediated transcriptional activation of USP28 in colorectal cancer (CRC) cells . Binds to the USP28 promoter in colorectal cancer (CRC) cells . .; FUNCTION: (Microbial infection) Upon Epstein-Barr virus (EBV) infection, binds to viral BZLF1 Z promoter and activates viral BZLF1 expression. . |
Accessions | A0AA34QVR9 ENST00000371222.4 ENST00000710273.1 ENST00000678696.1 P05412 Q6FHK0 |